A Time-Resolved Fluorescence Probe for Dipeptidyl Peptidase 4 and Its Application in Inhibitor Screening
- 11 October 2010
- journal article
- research article
- Published by Wiley in Chemistry – A European Journal
- Vol. 16 (45), 13479-13486
- https://doi.org/10.1002/chem.201001077
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Non-insulin therapies for type 2 diabetesNature Reviews Drug Discovery, 2007
- Dipeptidyl Peptidase-4 Inhibition and the Treatment of Type 2 DiabetesDiabetes Care, 2007
- [(S)-γ-(Arylamino)prolyl]thiazolidine compounds as a novel series of potent and stable DPP-IV inhibitorsBioorganic & Medicinal Chemistry, 2006
- Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 DiabetesJournal of Medicinal Chemistry, 2005
- (2R)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 DiabetesJournal of Medicinal Chemistry, 2004
- Global Prevalence of DiabetesDiabetes Care, 2004
- 1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic PropertiesJournal of Medicinal Chemistry, 2003
- 1-[2-[(5-Cyanopyridin-2-yl)amino]ethylamino]acetyl-2-(S)-pyrrolidinecarbonitrile: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic PropertiesJournal of Medicinal Chemistry, 2002
- Novel therapeutic strategies for the treatment of Type 2 diabetesDiabetes/Metabolism Research and Reviews, 1998
- Improved Glucose Tolerance in Zucker Fatty Rats by Oral Administration of the Dipeptidyl Peptidase IV Inhibitor Isoleucine ThiazolidideDiabetes, 1998